上海复旦张江生物医药股份有限公司（股票代码：01349，简称“复旦张江”）于2026年5月7日披露了截至2026年4月30日的证券变动月报表。根据公告，复旦张江在本月未有新增发行、回购、注销或库藏股等变动，股本结构维持稳定。
根据公告，复旦张江普通股包括H股和A股两大类：H股数量为326,000,000股，与上月末持平；A股（上海证券交易所科创板，代码：688505）数量为710,572,100股，亦与上月末持平。截至2026年4月30日，公司的注册股本总额维持在人民币103,657,210元。
报告指出，复旦张江当月无新增股份期权、股权激励计划变动，也无购回或注销行为。公司表示，其H股已满足香港联合交易所有限公司相关上市规则对公众持股量的要求。该公告由公司秘书薛燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.